Active repression by thyroid hormone receptor splicing variant α2 requires specific regulatory elements in the context of native triiodothyronine-regulated gene promoters

Endocrinology

Volumn 138, Issue 11, 1997, Pages 4705-4712

  Farsetti, A ^a,b,c   Lazar, J ^a   Phyillaier, M ^a   Lippoldt, R ^a   Pontecorvi, A ^b   Nikodem, V M ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b CATHOLIC UNIVERSITY   (Italy)

^c CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; MALATE DEHYDROGENASE (DECARBOXYLATING); MYELIN BASIC PROTEIN; THYROID HORMONE; THYROID HORMONE RECEPTOR;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; DNA BINDING; ELECTROPHORETIC MOBILITY; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; RECEPTOR BINDING; TATA BOX; TRANSACTIVATION; TRANSCRIPTION INITIATION;

EID: 0030782145     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.11.5541     Document Type: Article

References (41)

1. Beato M 1989 Gene regulation by steroid hormones. Cell 56:335-344
2. Glass C 1994 Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr Rev 15:391-407
3. Brent GA 1994 The molecular basis of thyroid hormone action. N Engl J Med 331:847-853
4. Mitsuhashi T, Tennyson GE, Nikodem VM 1988 Alternative splicing generates messages encoding rat c-ErbA proteins that do not bind thyroid hormone. Proc Natl Acad Sci USA 85:5804-5808
5. Lazar MA, Hodin RA, Darling DS, Chin WW 1988 Identification of a rat c-erbAα-related protein which binds deoxyribonucleic acid but does not bind thyroid hormone. Mol Endocrinol 2:893-901
6. Forman BM, Samuels HH 1990 Interactions among a subfamily of nuclear hormone receptors: the regulatory zinc finger. Mol Endocrinol 4:1293-1301
7. Au-Fliegner M, Helmer E, Casanova, Raaka BM, Samuels HH 1993 The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation. Mol Cell Biol 13:5725-5737
8. Nagaya T, Jameson JL 1993 Distinct dimerization domains provide antagonist pathways for thyroid hormone receptor action. J Biol Chem 268:24278-24282
9. Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterik RJ 1995 A structural role for hormone in the thyroid hormone receptor. Nature 378:681-689
10. Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, Moras D 1995 Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature 378:681-689
11. Koenig RJ, Lazar MA, Hodin RA, Brent GA, Larsen RP, Chin WW, Moore DD 1989 Inhibition of thyroid hormone action by a non-hormone binding c-erbA protein generated by alternative splicing. Nature 337:659-661
12. Lazar MA, Hodin RA, Chin WW 1989 Human carboxyl-terminal variant of α-type c-erb A inhibits trans-activation by thyroid hormone receptors without binding thyroid hormone. Proc Natl Acad Sci USA 86:7771-7774
13. Chatterjee VKK, Tata JR 1992 Thyroid hormone receptors and their role in development. Cancer Surv 14:147-167
14. Bradley DJ, Towle HC, Scott Young III W 1992 Spatial and temporal expression of α and β-thyroid hormone receptor mRNAs, including the β2 subtype, in the developing mammalian nervous system. J Neurosci 12:2288-2302
15. Forrest D, Sjoberg M, Vennstrom B 1990 Contrasting developmental and tissue-specific expression of α and β thyroid hormone receptor genes. EMBO J 9:1519-1528
16. Strait KA, Schwartz HL, Perez-Castillo A, Oppenheimer JH 1990 Relationship of c-erbA mRNA content to tissue triiodothyronine nuclear binding capacity and function in developing and adult rat. J Biol Chem 265:10514-10521
17. Schwartz HL, Strait KA, Ling NC, Oppenheimer JH 1992 Quantitation of rat tissue thyroid hormone binding receptor isoforms by immunoprecipitation of nuclear triiodothyronine binding capacity. J Biol Chem 267:11794-11799
18. Farsetti A, Desvergne B, Hallenbeck P, Robbins J, Nikodem VM 1992 Characterization of myelin basic protein thyroid hormone response element and its function in the context of native and heterologous promoter. J Biol Chem 267:15784-15788
19. Strait KA, Zou L, Oppenheimer JH 1992 β1 isoform-specific regulation of a triiodothyronine-induced gene during cerebellar development. Mol Endocrinol 6:1874-1880
20. Lezoualc'h F, Hassan AHS, Giraud P, Loeffler J-P, Lee SL, Demeneix BA 1992 Assignment of the β-thyroid hormone receptor to 3,5,3′-triiodothyronine-dependent inhibition of transcription from the thyrotropin-releasing hormone promoter in chick hypothalamic neurons. Mol Endocrinol 6:1797-1804
21. Lebel JM, Dussault JH 1994 The thyroid and brain development. Curr Opin Endocrinol Diabetes 1:167-174
22. Fondell JD, Brunel F, Hisatake K, Roeder RG 1996 Unliganded thyroid hormone receptor α can target TATA-binding protein for transcriptional repression. Mol Cell Biol 16:281-287
23. Schulman IG, Juguilon H, Evans RM 1996 Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states. Mol Cell Biol 16:3807-3816
24. Rentoumis A, Chatterjee KK, Madison LD, Datta S, Gallagher GD, DeGroot LJ, Jameson JL 1990 Negative and positive transcriptional regulation by thyroid hormone receptor isoforms. Mol Endocrinol 4:1522-1531
25. Katz D, Berrodin TJ, Lazar MA 1992 The unique C-termini of the thyroid hormone receptor variant, c-erbAα2, and thyroid hormone receptor α1 mediate different DNA-binding and heterodimerization properties. Mol Endocrinol 6:805-814
26. Yen PM, Chin WW 1994 Molecular mechanisms of dominant negative activity by nuclear hormone receptors. Mol Endocrinol 8:1450-1454
27. Katz D, Lazar MA 1993 Dominant negative activity of an endogenous thyroid hormone receptor variant (α2) is due to competition for binding sites on target genes. J Biol Chem 268:20904-20910
28. Liu RT, Suzuki S, Miyamoto T, Takeda T, Ozata M, DeGroot LJ 1995 The dominant negative effect of thyroid hormone receptor splicing variant α2 does not require binding to a thyroid response element. Mol Endocrinol 9:86-95
29. Petty KJ 11th International Thyroid Congress, Toronto. Thyroid [Supp 1] 5:S-135 (Abstract 268)
30. Farsetti A, Mitsuhashi T, Desvergne B, Robbins J, Nikodem VM 1991 Molecular basis of thyroid hormone regulation of myelin basic protein gene expression in rodent brain. J Biol Chem 266:23226-23232
31. Morioka H, Tennyson GE, Nikodem VM 1988 Structural and Functional analysis of the rat malic enzyme gene promoter. Mol Cell Biol 8:3542-3545
32. Desvergne B, Petty KJ, Nikodem VM 1991 Functional characterization and receptor binding studies of the malic enzyme thyroid hormone response element. J Biol Chem 266:1008-1013
33. Katz D, Reginato MJ, Lazar MA 1995 Functional regulation of thyroid hormone receptor variant TRα2 by phosphorilation. Mol Cell Biol 15:2341-2348
34. Petty JK 1995 Tissue- and cell-specific distribution of proteins that interact with the human thyroid hormone receptor-β. Mol Cell Endocrinol 108:131-142
35. Tong GX, Tanen MR, Bagchi MK 1995 Ligand modulates the interaction of thyroid hormone receptor β with the basal transcription machinery. J Biol Chem 270:10601-10611
36. Yang YZ, Burgos-Trinidad M, Wu Y, Koenig RJ 1996 Thyroid hormone receptor variant α2. J Biol Chem 271:28235-28242
37. Reginato MJ, Zhang J, Lazar MA 1996 DNA-independent and DNA-dependent mechanisms regulate the differential heterodimerization of the isoforms of the thyroid hormone receptor with retinoid X receptor. J Biol Chem 271:28199-28205
38. Levine M, Manley JL 1989 Transcriptional repression of eukaryotic promoters. Cell 59:405-408
39. Hanna-Rose W, Hansen U 1996 Active repression mechanisms of eukaryotic transcription repressors. Trends Genet 12:229-234
40. Fondell JD, Roy AL, Roeder RG 1993 Unliganded thyroid hormone receptor inhibits formation of a functional preinitiation complex: implications for active repression. Genes Dev 7:1400-141017
41. Tong GX, Jeyakumar M, Tanen MR, Bagchi MK 1996 Transcriptional silencing by unliganded thyroid hormone receptor β requires a soluble corepressor that interacts with the ligand-binding domain of the receptor. Mol Cell Biol 16:1909-1920